157 related articles for article (PubMed ID: 7146408)
1. Perfluoroctylbromide: a reticuloendothelial-specific and tumor-imaging agent for computed tomography.
Mattrey RF; Long DM; Multer F; Mitten R; Higgins CB
Radiology; 1982 Dec; 145(3):755-8. PubMed ID: 7146408
[TBL] [Abstract][Full Text] [Related]
2. Perfluoroctylbromide: a liver/spleen-specific and tumor-imaging ultrasound contrast material.
Mattrey RF; Scheible FW; Gosink BB; Leopold GR; Long DM; Higgins CB
Radiology; 1982 Dec; 145(3):759-62. PubMed ID: 7146409
[TBL] [Abstract][Full Text] [Related]
3. [Imaging of tumor, liver and spleen with computed tomography (CT) using perfluoroctylbromide emulsion (PFOB)].
Murata K
Nihon Gan Chiryo Gakkai Shi; 1988 Jan; 23(1):104-13. PubMed ID: 3379326
[No Abstract] [Full Text] [Related]
4. Perfluoroctylbromide as a blood pool contrast agent for liver, spleen, and vascular imaging in computed tomography.
Mattrey RF; Long DM; Peck WW; Slutsky RA; Higgins CB
J Comput Assist Tomogr; 1984 Aug; 8(4):739-44. PubMed ID: 6736376
[TBL] [Abstract][Full Text] [Related]
5. Experimental comparison of EOE-13 and perfluoroctylbromide for the CT detection of hepatic metastases.
Patronas N; Miller DL; Girton M
Invest Radiol; 1984; 19(6):570-3. PubMed ID: 6096289
[TBL] [Abstract][Full Text] [Related]
6. Computed tomographic enhancement of the liver, liver abscesses, spleen, and major vessels with perfluorooctylbromide emulsion. Influence of dosage and injection velocity in an animal model.
Adam G; Günther RW; Schiffer C; Görtz H; Prescher A; Scherer K
Invest Radiol; 1992 Sep; 27(9):698-705. PubMed ID: 1399453
[TBL] [Abstract][Full Text] [Related]
7. Liver, spleen, and vessels: preliminary clinical results of CT with perfluorooctylbromide.
Bruneton JN; Falewée MN; François E; Cambon P; Philip C; Riess JG; Balu-Maestro C; Rogopoulos A
Radiology; 1989 Jan; 170(1 Pt 1):179-83. PubMed ID: 2909093
[TBL] [Abstract][Full Text] [Related]
8. Specific enhancement of intra-abdominal abscesses with perfluoroctylbromide for CT imaging.
Mattrey RF; Andrè M; Campbell J; Mitten R; Multer F; Hackney D; Long DM; Higgins CB
Invest Radiol; 1984; 19(5):438-46. PubMed ID: 6511250
[TBL] [Abstract][Full Text] [Related]
9. Perfluoroctylbromide and hepatosplenic computed tomography. Preliminary clinical study.
Bruneton JN; Falewee MN; Balu-Maestro C; Normand F; Mattrey RF
Invest Radiol; 1988 Sep; 23 Suppl 1():S306-7. PubMed ID: 3198367
[TBL] [Abstract][Full Text] [Related]
10. [Computed tomographic studies on density kinetics after the bolus injection and infusion of perfluorooctylbromide (PFOB). Animal experimental studies].
Adam G; Günther RW; Prescher A; Goertz H; Schiffer C; Bruchmüller K; Limmer J
Rofo; 1992 May; 156(5):487-91. PubMed ID: 1596555
[TBL] [Abstract][Full Text] [Related]
11. [Tumor imaging effects of perfluoroctylbromide (PFOB) emulsion].
Murata K; Itoh Y; Ayakawa Y; Miyata N
Nihon Gan Chiryo Gakkai Shi; 1988 Dec; 23(11):2669-78. PubMed ID: 3249107
[No Abstract] [Full Text] [Related]
12. Use of perfluorooctylbromide (PFOB) to detect liver abscesses with computed tomography. Safety and efficacy.
Mattrey RF; Brown JJ; Shelton RE; Ogino MT; Johnson KK; Mitten RM
Invest Radiol; 1991 Sep; 26(9):792-8. PubMed ID: 1938289
[TBL] [Abstract][Full Text] [Related]
13. Perfluoroctylbromide contrast enhancement of malignant neoplasms: preliminary observations.
Young SW; Enzmann DR; Long DM; Muller HH
AJR Am J Roentgenol; 1981 Jul; 137(1):141-6. PubMed ID: 6787865
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Fenestra LC, ExiTron nano 6000, and ExiTron nano 12000 for micro-CT imaging of liver and spleen in mice.
Boll H; Figueiredo G; Fiebig T; Nittka S; Doyon F; Kerl HU; Nölte I; Förster A; Kramer M; Brockmann MA
Acad Radiol; 2013 Sep; 20(9):1137-43. PubMed ID: 23931428
[TBL] [Abstract][Full Text] [Related]
15. Improved detectability of VX2 carcinoma in the rabbit liver with contrast enhancement in computed tomography.
Violante MR; Dean PB
Radiology; 1980 Jan; 134(1):237-9. PubMed ID: 7350611
[TBL] [Abstract][Full Text] [Related]
16. Time versus density enhancement of liver, spleen, and great vessels following rapid intravenous infusion of perflubron emulsion.
Harned RK; Fruman SA; Swenson RB; Bernardino ME
Acad Radiol; 1995 Jan; 2(1):38-42. PubMed ID: 9419522
[TBL] [Abstract][Full Text] [Related]
17. Perfluorooctylbromide as a contrast agent for CT and sonography: preliminary clinical results.
Behan M; O'Connell D; Mattrey RF; Carney DN
AJR Am J Roentgenol; 1993 Feb; 160(2):399-405. PubMed ID: 8424361
[TBL] [Abstract][Full Text] [Related]
18. CT of the liver and spleen with EOE-13: review of 225 examinations.
Miller DL; Vermess M; Doppman JL; Simon RM; Sugarbaker PH; O'Leary TJ; Grimes G; Chatterji DG; Willis M
AJR Am J Roentgenol; 1984 Aug; 143(2):235-43. PubMed ID: 6331144
[TBL] [Abstract][Full Text] [Related]
19. Dynamic evolutionary changes in blood flow measured by MDCT in a hepatic VX2 tumor implant over an extended 28-day growth period: time-density curve analysis.
Wu H; Exner AA; Shi H; Bear J; Haaga JR
Acad Radiol; 2009 Dec; 16(12):1483-92. PubMed ID: 19896066
[TBL] [Abstract][Full Text] [Related]
20. Perfluoroctylbromide as a contrast agent for computed tomographic imaging of septic and aseptic arthritis.
Sartoris DJ; Guerra J; Mattrey RF; Resnick D; Haghighi P; Mitten R; Trudell D; Pate D
Invest Radiol; 1986 Jan; 21(1):49-55. PubMed ID: 3943957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
